Fingerprint
Dive into the research topics where Julie Niemann Pedersen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 2 Journal article
-
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial
Klausen, M. K., Justesen, S. K., Pedersen, J. N., Rasmussen, L., Jensen, A., Jensen, M. E., Knorr, U. B., Bergmann, M. L., Holst, J. J., Hartmann, B., Koob, G. F., Benveniste, H., Volkow, N. D., Ekstrøm, C. T., Knudsen, G. M., Vilsbøll, T. & Fink-Jensen, A., 2 May 2026, In: The Lancet. 407, 10540, p. 1687-1698 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)
Klausen, M. K., Kuzey, T., Pedersen, J. N., Justesen, S. K., Rasmussen, L., Knorr, U. B., Mason, G., Ekstrøm, C. T., Holst, J. J., Koob, G., Benveniste, H., Volkow, N. D., Knudsen, G. M., Vilsbøll, T. & Fink-Jensen, A., 8 Jan 2025, In: BMJ Open. 15, 1, e086454.Research output: Contribution to journal › Journal article › Research › peer-review
10 Citations (Scopus)